ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the novel combined oral contraceptive NEXTSTELLIS® (14.2 mg of estetrol and 3 mg drospirenone tablets). Mayne...
PayNuts, one of Australia’s fastest-growing payment service providers, has unveiled a refreshed brand identity and an expanded suite of integrated b...
Australian small business owners can now receive and compare business insurance quotes directly inside ChatGPT, in a move that signals a major shi...
With only 16% of retiring small businesses having a succession plan, tens of thousands risk closure as one in three owners nears retirement. Ne...
As workplaces settle into the new year and look for ways to strengthen culture, capability and connection, experts say corporate volunteering is e...
Global Hospitality Platform, Tabit, Reveals Five Ways to Maximise Benefits of Mobile-First Systems As Australian hospitality venues grapple with...
For over a decade, the most practical and effective advice we could offer an employee was to spot the typo. It was practical, it was free, and it wo...